Skip to main content

Lion To Use Paracel's GeneMatcher; Pharmacia Licenses Lion's BioScout


HEIDELBERG--Lion Bioscience announced last week that it has agreed to purchase the GeneMatcher genetic data analysis system from Pasadena, Calif.-based Paracel. In a separate deal, Lion also licensed its BioScout integrated bioinformatics system for three years to Pharmacia & Upjohn.

Lion will use the Paracel system in genetic sequence characterization as a component of a high-throughput alert system for identifying novel target genes. This new technology will allow users of Lion's BioScout and SRS Life Science Informatics systems to search public and proprietary databases quickly and accurately for genes of interest, on a daily basis, said Lion.

Linking the platforms will allow researchers to screen large volumes of sequence and literature data relevant to industrial gene discovery research, according to Lion. These integrated solutions will enable pharmaceutical, agricultural, and biotech companies to maximize the outcome of genomics-based discovery programs in terms of novel and better validated target genes, the company said.

The agreement with Pharmacia & Upjohn calls for Lion to integrate Pharmacia's existing in-house bioinformatics systems with the BioScout platform. The software, which simultaneously accesses information from different private and public genetics databases, will be installed at Pharmacia's research site in Sweden and will be made accessible to its other research sites around the globe. As part of the arrangement, Lion will also provide user support and training for the duration of the contract.

Filed under

The Scan

Not Kept "Clean and Sanitary"

A Food and Drug Administration inspection uncovered problems with cross contamination at an Emergent BioSolutions facility, the Wall Street Journal reports.

Resumption Recommendation Expected

The Washington Post reports that US officials are expected to give the go-ahead to resume using Johnson & Johnson's SARS-CoV-2 vaccine.

Canada's New Budget on Science

Science writes that Canada's new budget includes funding for the life sciences, but not as much as hoped for investigator-driven research.

Nature Papers Examine Single-Cell, Multi-Omic SARS-CoV-2 Response; Flatfish Sequences; More

In Nature this week: single-cell, multi-omics analysis provides insight into COVID-19 pathogenesis, evolution of flatfish, and more.